Oral delivery a possibility for silica-based C'Dots
November 27, 2023
November 27, 2023
ITHACA, New York, Nov. 27 -- Cornell University issued the following news:
Take a pill, or get a shot? Given the choice, most people would likely go for the former.
Ultrasmall fluorescent core-shell hybrid silica nanoparticles - known as Cornell Prime Dots, or C'Dots - are among the nanocarriers for therapeutics that were thought to be viable only by injection, but new Cornell research has shown the potential for their oral administration.
"Because the . . .
Take a pill, or get a shot? Given the choice, most people would likely go for the former.
Ultrasmall fluorescent core-shell hybrid silica nanoparticles - known as Cornell Prime Dots, or C'Dots - are among the nanocarriers for therapeutics that were thought to be viable only by injection, but new Cornell research has shown the potential for their oral administration.
"Because the . . .